You searched for "elective"

2009 results found

Low-dose atropine 0.01% for the treatment of childhood myopia: a pan-India multicentric retrospective study

This is a retrospective multicentre study (20 centres) in India over two years, monitoring the progression of myopia after starting treatment with 0.01% atropine drops. Seven-hundred and thirty-two children were recruited in the study, between six and 14 years old,...

Repeat corneal collagen cross-linking after failure of primary cross-linking (CXL) in keratoconus

This is a 10-year, retrospective, patients record review from Leeds, UK. Twenty-one eyes had repeated CXL and the mean interval between primary and repeat CXL was 47.1 months. Twenty (95%) eyes stabilised after repeated CXL at a mean follow-up of...

Paediatric ophthalmology five-year results of atropine 0.01% efficacy in the myopia control in a European population

This a prospective, randomised and longitudinal study from Madrid, Spain in 361 eyes from 361 children randomised into the control group (177 eyes with no treatment) and the treatment group (184 eyes with 0.01% atropine drops once daily). Complete eye...

One vs two muscle surgery results for small / moderate angle horizontal strabismus

The authors aimed to compare the long-term surgical outcomes of one vs two muscle surgery in 89 patients with horizontal strabismus of small to moderate angle (<25PD). This was a retrospective study with a minimum six-month follow-up period. One muscle...

Treatment of vertical diplopia in the reading position

This paper describes the use of slab-off prisms for the treatment of vertical diplopia in the reading position. The following data were collected: main symptom complaint, visual acuity, refractive error, binocular vision including sensory fusion and stereoacuity, alternating cover test...

Treatment for chronic severe bilateral blepharokeratoconjunctivitis

This study evaluated the efficacy and safety of oral azithromycin treatment combined with topical antibiotics and anti-inflammatory agents in paediatric patients with chronic severe bilateral blepharokeratoconjunctivitis (BKC). The authors recruited 29 consecutive patients (58 eyes) with mean age at diagnosis...

Heidelberg Engineering announces partnership with Hospital Services Ltd for distribution and service in Ireland

Heidelberg Engineering is excited to announce a strategic partnership with Hospital Services Ltd (HSL), which will take over as the exclusive distributor and service provider of the Heidelberg Engineering range of products in the Republic of Ireland, effective 1st July...

Inferior oblique botulinum toxin as a postoperative test

The authors aimed to evaluate the role of inferior oblique (IO) botulinum toxin (BT) injection as a surgical simulator prior to IO myectomy, i.e. preoperative diplopia test using BT. This was a retrospective review in a single centre over a...

BTA as a first-line treatment option for acute acquired comitant esotropia

This study presents results of a single-centre institute use of botulinum toxin A (BTA) as an initial treatment choice for acute acquired comitant esotropia (AACE). This was a prospective observational case series study of 72 patients (49 male, 23 female)...

BT as an effective alternative treatment for small angle consecutive exotropia

In this study, the authors evaluate the efficacy of botulinum toxin A (BTA) as a treatment option for consecutive exotropia. This was a retrospective review of 34 patients; 23 female and 11 male. Age at BTA was a mean of...

Use of reduced volume BT as a treatment option for acute onset comitant esotropia

In this study, the effectiveness and safety of botulinum toxin (BT) for patients with acute acquired comitant esotropia (AACE) and deviation ≤25PD was investigated with comparison of results to conservative prism therapy. Botulinum toxin was undertaken without electromyographic guidance and...

The College of Optometrists calls for shift in detecting and managing glaucoma

The College of Optometrists calls for shift in detecting and managing glaucoma by fully unlocking safe and effective primary care capacity Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people,...